Efficacy of Fascia Exercises in Migraine Patients
- Disease/Condition
- Migraine
- Drug/Device/Intervention
- Fascia exercises
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Ankara Yildirim Beyazıt University
- Location
- Ankara, Turkey
- Phase
- N/A
- Start date
- Oct 10, 2022
- End date
- Sep 10, 2023
- Enrollment
- 30 participants
Heart rate variability
Migraine, which is characterized by attacks and many accompanying symptoms, negatively
 affects the quality of life of patients. Although different methods have been tried for
 migraine, there is no definitive treatment approach yet. The aim of this study is to examine
 the effect of fascia exercises as a new approach on the symptoms and complaints of migraine
 patients.
 
 The study was completed with 30 volunteer migraine patients. Participants were divided into
 two groups in a randomized controlled manner. While head-neck and breathing exercises were
 applied to the control group, fascial pattern exercises were performed in the study group in
 addition to these exercises. This protocol was applied 2 days a week for 6 weeks. Pain
 intensity, quality of life and sleep, heart rate changes, depression and anxiety levels and
 satisfaction levels were evaluated before and after the treatment.
 
 Fascial pattern exercises are an effective approach on the symptoms and complaints of
 migraine patients and can be adopted as a complementary application in migraine treatment.
 Since this is the first study in this field, it needs to be supported by other studies in
 order to increase the provability of the effectiveness of the exercises.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06231615
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06231615 through Pure Global AI's free database. This phase not specified trial is sponsored by Ankara Yildirim Beyazıt University and is currently Completed. The study focuses on Migraine. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.